320 related articles for article (PubMed ID: 35459272)
1. Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma.
Fang C; Liu S; Feng K; Huang C; Zhang Y; Wang J; Lin H; Wang J; Zhong C
Sci Rep; 2022 Apr; 12(1):6642. PubMed ID: 35459272
[TBL] [Abstract][Full Text] [Related]
2. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC.
Wang W; Wang L; Song C; Mu T; Hu J; Feng H
J Gastrointest Cancer; 2024 Mar; 55(1):444-456. PubMed ID: 38006465
[TBL] [Abstract][Full Text] [Related]
4. A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma.
Lin X; Yang S
Adv Clin Exp Med; 2022 Oct; 31(10):1099-1109. PubMed ID: 35581934
[TBL] [Abstract][Full Text] [Related]
5. A ferroptosis-associated lncRNAs signature predicts the prognosis of hepatocellular carcinoma.
Wang D; Zhang L; Zhang Y; Zhang Y; Xu S
Medicine (Baltimore); 2022 Jul; 101(28):e29546. PubMed ID: 35839000
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma.
Yang X; Mei M; Yang J; Guo J; Du F; Liu S
Aging (Albany NY); 2022 May; 14(9):4069-4084. PubMed ID: 35550563
[TBL] [Abstract][Full Text] [Related]
7. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
Front Immunol; 2022; 13():929089. PubMed ID: 35874689
[TBL] [Abstract][Full Text] [Related]
8. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.
Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ
Front Oncol; 2021; 11():738477. PubMed ID: 34568075
[TBL] [Abstract][Full Text] [Related]
10. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer.
Wang Y; Xu Y; Zhang Y
Medicine (Baltimore); 2022 Aug; 101(31):e29573. PubMed ID: 35945765
[TBL] [Abstract][Full Text] [Related]
11. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
13. Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma.
Xie H; Shi M; Liu Y; Cheng C; Song L; Ding Z; Jin H; Cui X; Wang Y; Yao D; Wang P; Yao M; Zhang H
Front Immunol; 2022; 13():914977. PubMed ID: 36032107
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
Front Immunol; 2022; 13():922315. PubMed ID: 35774794
[TBL] [Abstract][Full Text] [Related]
15. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma.
Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S
Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858
[TBL] [Abstract][Full Text] [Related]
16. Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer.
Lin Y; Gan F; He X; Deng H; Li Y
J Immunol Res; 2022; 2022():5893998. PubMed ID: 35915656
[TBL] [Abstract][Full Text] [Related]
17. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
Xu L; Zheng Q; Liu W
BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
[TBL] [Abstract][Full Text] [Related]
18. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
Front Genet; 2021; 12():682082. PubMed ID: 34745200
[No Abstract] [Full Text] [Related]
20. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
